|
1. Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011;144(5): 646-74. 2. Collado M, Serrano M. Senescence in tumours: Evidence from mice and humans. Nature Reviews Cancer 2010;10(1): 51-57. 3. Burkhart DL, Sage J. Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nature Reviews Cancer 2008;8(9): 671-82. 4. Berdasco M, Esteller M. Aberrant epigenetic landscape in cancer: How cellular identitygoes awry. Developmental Cell 2010;19(5): 698-711. 5. Adams JM, Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 2007;26(9): 1324-37. 6. Cong Y, Shay JW. Actions of human telomerase beyond telomeres. Cell Research 2008;18(7): 725-32. 7. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86(3): 353-64. 8. Gewirtz DA. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics Adriamycin and daunorubicin. Biochemical Pharmacology 1999;57(7): 727-41. 9. Mizutani H, Tada-Oikawa S, Hiraku Y, Kojima M, Kawanishi S. Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide. Life Sciences 2005;76(13): 1439-53. 10. Chou HH, Wang KL, Chen CA, Wei LH, Lai CH, Hsieh CY, Yang YC, Twu NF, Chang TC, Yen MS. Pegylated liposomal doxorubicin (Lipo-Dox (R)) for platinum-resistant or refractory epithelial ovarian carcinoma: A Taiwanese gynecologic oncology group study with long-term follow-up. Gynecologic Oncology 2006;101(3): 423-28. 11. Koning GA, Eggermont AM, Lindner LH, ten Hagen TL. Hyperthermia and thermosensitive liposomes for improved delivery of chemotherapeutic drugs to solid tumors. Pharmaceutical Research 2010;27(8): 1750. 12. Chinthalapally VR, Abraham R, Barbara S, Bandaru SR. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Research 1995;55(2): 259. 13. Sharma RA, Gescher AJ, Steward WP. Curcumin: The story so far. European Journal of Cancer 2005;41(13): 1955-68. 14. Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Research 2003;23(1A): 363-98. 15. Sharma RA. Phase I clinical trial of oral curcumin biomarkers of systemic activity and compliance. Clinical Cancer Research 2004;10(20): 6847. 16. Suneet S, Hani Z, Anika H, Bjorn B, Joseph AW, Suresh VA. Curcumin inhibits the activity of ABCG2/BCRP1, a multidrug resistance-linked ABC drug transporter in mice. Pharmaceutical Research 2009;26(2): 480. 17. Zuo L, Christofi FL, Wright VP, Liu CY, Merola AJ, Berliner LJ, Clanton TL.. Intra-and extracellular measurement of reactive oxygen species produced during heat stress in diaphragm muscle. American Journal of Physiology Cell Physiology 2000;279(4): C1058. 18. Fiorentini G, Szasz A. Hyperthermia today: Electric energy, a new opportunity in cancer treatment. Journal of Cancer Research and Therapeutics 2006;2(2): 41-46. 19. Grull H, Langereis S. Hyperthermia-triggered drug delivery from temperature-sensitive liposomes using MRI-guided high intensity focused ultrasound. Journal of Controlled Release 2012;161(2): 317-27. 20. Tonnesen HH, Masson M, Loftsson T. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. International Journal of Pharmaceutics 2002;244(1-2): 127-35. 21. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: Problems and promises. Molecular Pharmacology 2007;4(6): 807-18. 22. Koning GA, Eggermont AM, Lindner LH, ten Hagen TL. Hyperthermia and thermosensitive liposomes for improved delivery of chemotherapeutic drugs to solid tumors. Pharmaceutical Research 2010;27(8): 1750.
|